
研究组
肿瘤病因及系统性调控研究组
日期:2023-03-16课题组长
屠红博士,研究员,博士研究生 导师
研究方向
1. 消化系统肿瘤的系统性调控
2. HBV相关肿瘤的分子机制研究
近年科研项目
1. 国家自然科学基金青年项目,82203173,良性心理应激通过肠道菌群/胆汁酸代谢/NKT细胞调控轴抑制肿瘤肝转移的机制研究,2023.01-2025.12
2. 国家自然科学基金面上项目,82173381,良性心理应激通过肠道菌群调控Th17/Treg免疫功能发挥抗胰腺癌作用,2022.1-2025.12
3. 国家自然科学基金青年科学基金项目,82103020,热量限制通过HIG2/ATGL通路调控中性粒细胞脂质代谢抑制肿瘤生长的机理研究,2022.01-2024.12
4. 上海市科委杨帆计划,21YF1445300,能量限制对肿瘤机体中性粒细胞促肿瘤活性进行抑制的机理研究,2021.05-2024.04
5. 国家自然科学基金面上项目,82073406,能量限制联合良性心理应激增强NK细胞抗肿瘤活性并抑制其衰竭的机制研究,2021.01-2024.12
6. 国家自然科学基金面上项目,81872505,良性心理应激通过调控线粒体能量代谢途径抑制肿瘤生长的机制研究,2019.01-2022.12
7. 国家“十三五”科技重大专项,2017ZX10201201-008-003,不同危险度社区成人乙肝重点人群干预策略的研究与应用效果评价,2017.01-2020.12
8. 国家重点研发计划精准医学研究专项,2017YFC0908103,肝癌/肝病临床和社区人群大型队列研究,2017.01-2020.12
科研奖励:
1. 江苏省科技奖三等奖(2022年)
2. 国家自然科学奖二等奖(2019年)
3. 上海市科技进步奖一等奖(2018年)
4. 教育部度高等学校科学研究优秀成果奖一等奖(2018年)
团队成员
甘愉 博士,研究员,青年研究组长,博士生研究生导师
杜旻 博士,副研究员
高见 博士,助理研究员
李倩 博士,助理研究员
李慧敏 硕士,研究实习员
代表性论文
1. Liu T*, Li J*, Li Q, Liang Y, Gao J, Meng Z, Li P, Yao M, Gu J#, Tu H#, Gan Y#. Environmental eustress promotes liver regeneration via the sympathetic regulation of type 1 innate lymphoid cells to increase IL-22 in mice. Hepatology. 2023 Jan 13. doi: 10.1097/HEP.0000000000000239. Online ahead of print.
2. Zhao D*, Yuan H*, Fang Y*, Gao J, Li H, Li M, Cong H, Zhang C, Liang Y, Li J, Yang H, Yao M, Du M#, Tu H#, Gan Y#. Histone Methyltransferase KMT2B Promotes Metastasis and Angiogenesis of Cervical Cancer by Upregulating EGF Expression. Int J Biol Sci. 2023,19:34-49.
3. Cong H, Gao J, Wang Q, Du M, Li H, Li Q, Li J, Liang Y, Zhao D, Yang H, Gan Y#, Tu H#. Increased expression of mitochondrial UQCRC1 in pancreatic cancer impairs antitumor immunity of natural killer cells via elevating extracellular ATP. Front Oncol. 2022 13:872017
4. Liang Y*, Li H*, Gan Y#, Tu H#. Shedding Light on the Role of Neurotransmitters in the Microenvironment of Pancreatic Cancer. Front Cell Dev Biol. 2021 9:688953.
5. Yang C*, Yuan H*, Gu J, Xu D, Wang M, Qiao J, Yang X, Zhang J, Yao M, Gu J, Tu H#, Gan Y#. ABCA8-mediated efflux of taurocholic acid contributes to gemcitabine insensitivity in human pancreatic cancer via the S1PR2-ERK pathway. Cell Death Discov. 2021 7(1):6.
6. Wang Q*, Li M*, Gan Y, Jiang S, Qiao J, Zhang W, Fan Y, Shen Y, Song Y, Meng Z, Yao M, Gu J, Zhang Z, Tu H#. Mitochondrial protein UQCRC1 is oncogenic and a potential therapeutic target for pancreatic cancer. Theranostics. 2020, 10(5):2141-2157.
7. Li M, Shen Y, Chen Y, Gao H, Zhou J, Wang Q, Fan C, Zhang W, Li J, Cong H, Gu J, Gan Y, Tu H#. Characterization of hepatitis B virus infection and viral DNA integration in non-Hodgkin lymphoma. Int J Cancer, 2020, 147(8):2199-2209.
8. Fan C, Li M, Gan Y, Chen T, Sun Y, Lu J, Wang J, Jin Y, Lu J, Qian G, Gu J, Chen J, Tu H#. A simple AGED score for risk classification of primary liver cancer: development and validation with long-term prospective HBsAg-positive cohorts in Qidong, China. Gut. 2018, 68(5):948-949.
9. Li M*, Gan Y*, Fan C, Yuan H, Zhang X, Shen Y, Wang Q, Meng Z, Xu D, Tu H#. Hepatitis B virus and risk of non-Hodgkin lymphoma: An updated meta-analysis of 58 studies. J Viral Hepat. 2018, 25(8):894-903.
10. Song Y*, Gan Y*,#, Wang Q, Meng Z, Li G, Shen Y, Wu Y, Li P, Yao M, Gu J, Tu H#. Enriching the Housing Environment for Mice Enhances Their NK Cell Antitumor Immunity via Sympathetic Nerve-Dependent Regulation of NKG2D and CCR5. Cancer Research. 2017 77(7): 1611-22
11. Wu Y*, Gan Y*, Yuan H, Wang Q, Fan Y, Li G, Zhang J, Yao M, Gu J, Tu H#. Enriched environment housing enhances the sensitivity of mouse pancreatic cancer to chemotherapeutic agents. Biochem Biophys Res Commun. 2016, 473(2):593-9.
12. Fan Y*, Gan Y*, Shen Y, Cai X, Song Y, Zhao F, Yao M, Gu J, Tu H#. Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production. Oncotarget. 2015, 6(18): 16120-34.
13. Li G*, Gan Y*, Fan Y, Wu Y, Lin H, Song Y, Cai X, Yu X, Pan W, Yao M, Gu J, Tu H#. Enriched environment inhibits mouse pancreatic cancer growth and down-regulates the expression of mitochondria-related genes in cancer cells. Sci Rep. 2015, 5:7856.
14. Yan Jin, Hengjun Gao, Hao Chen, Jian Wang, Min Chen, Guohua Li, Liwei Wang, Jianren Gu, Hong Tu#. Identification and impact of hepatitis B virus DNA and antigens in pancreatic cancer tissues and adjacent non-cancerous tissues. Cancer Lett. 2013, 335:447-54.
15. Bai X, Zhu Y, Jin Y, Guo X, Qian G, Chen T, Zhang J, Wang J, Groopman JD, Gu J, Tu H#. Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high-risk for hepatocellular carcinoma Carcinogenesis, 2011, 32:63-8.
16. Guo X, Jin Y, Qian G, Tu H#. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J Hepatol. 2008, 49(5):718-25.